Focus

Cerebrolysin.

Available Variants

60 mg

View lab reports Quality process

Research area: Focus

🛡️

For research purposes only. Not intended for use in humans or animals.

Neuroscience research

About Cerebrolysin

Cerebrolysin is studied in the context of neuroscience and cognitive research. Proposed to exert multimodal neurotrophic and neuroprotective effects, including modulation of neuronal survival pathways, reduced excitotoxicity and inflammation, and stimulation of neuroplasticity through structural mimicry of endogenous growth factors.

Research Application

Studied in randomized controlled trials for post-stroke motor recovery (CARS trial series), traumatic brain injury recovery (CAPTAIN trial series), and as adjunct treatment in Alzheimer's disease.

Important to know

Claims circulating online are often not backed by valid clinical data. Treat all information as a starting point for your own scientific research, not as usage guidance.

Content 60 mg

Form Lyophilized powder

Category Focus

Purity & Identity see lab reports →

Sequence / Structure Not a single defined peptide — a standardized mixture of low-molecular-weight peptide fragments (<10,000 Da, ~25% of mass) and free amino acids (~75%), produced by enzymatic hydrolysis of porcine brain protein. Contains fragments structurally related to neurotrophic factors including BDNF, GDNF, NGF, CNTF, and IGF-1/IGF-2.

Regulatory Status Approved as a prescription drug in more than 50 countries (including Austria, Russia, China, South Korea) for stroke, traumatic brain injury, and dementia-related indications; manufactured by EVER Neuro Pharma. NOT FDA-approved in the US, no centralized EU approval.

Sequence and regulatory status data are based on publicly available sources and refer to the compound in general, not to a specific product.

Research Overview

Studies on neuroscience-related peptides are predominantly preclinical.

Muresanu DF, et al. Stroke. 2016;47(1):151–159. PMID 26564102
Gauthier S, et al. Dement Geriatr Cogn Disord. 2015;39(5-6):332–347. PMID 25832905
Poon W, et al. Neurol Sci. 2020;41(2):281–293. PMID 31494820

References without a PMID can be located via the respective publisher. This overview does not claim to be exhaustive.

Similar Peptides

Focus Cortagen View → Regeneration Thymalin View → Focus P21 View → Focus Pinealon View →

Question about Cerebrolysin?

We reply personally – via email or Telegram.

✉️ Email ✈️ Telegram

← Back to overview